Who invested in Akoya Biosciences

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Funding summaryUpdated 26 Oct 2026

$94Mraised across 2 rounds since 2019, from 2 sources

$50MRound$44MRound

Latest round: Round, $44MJun 2023
Biggest round: $50MRound · Dec 2019
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020202120222023

$50MRound$44MRound

First round: Round, $50M
Biggest round: $50M
Between rounds: 3.5 years

The rounds

Jun 2023
Round$44M
No investor was named in the report.
Source recorded
Dec 2019
Round$50M1 new
- Piper Jaffray
Reported by FinSMEs

Founders and team

From Akoya Biosciences's own website and the SEC filings it signed: 12 on the team.

Everett CunninghamChief Executive Officer
Anthony CatalanoChief Operating Officer
Daniel CharChief Legal Officer
Dr. Yuri FeskoChief Medical Officer
Erica BellChief People Officer
Jason FaesslerChief Financial Officer
Jim GuteChief Commercial Officer
Michael MillerChief Technology and Product Officer
Naren BhatChief Strategy Officer
Bill DonnellyDirector, Retired EVP, Mettler-Toledo International
Brian McKelligonExecutive Officer, Directori
Rob HartExecutive Officeri

On the board, as filediGarry NolanMatthew WinklerRobert SheplerThomas Raffin

Everyone who backed them

Piper JaffrayCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Akoya Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.